James I. Barnes

Statistics

Publications

Citations

509

H-Index

Active since

2018

Affiliations

VA Palo Alto Health Care System(Current)

Stanford University

Center for Innovation

James I. Barnes is an author at VA Palo Alto Health Care System specializing in cost-effectiveness modeling, pharmacoeconomics, and cost-effectiveness analysis.

ORCID

Publications per year

2018–2020

Publications

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma

John K. Lin, Lori Muffly, Michael A. Spinner et al. · Journal of Clinical Oncology · 2019 · 230 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia

John K. Lin, Benjamin Lerman, James I. Barnes et al. · Journal of Clinical Oncology · 2018 · 144 citations

Pharmacy, Oncology, Pharmacoeconomics +17

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p

James I. Barnes, Vasu Divi, Adrian Begaye et al. · Blood Advances · 2018 · 48 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +6

Cost-Effectiveness of Open Versus Endoscopic Carpal Tunnel Release

James I. Barnes, Gabrielle M. Paci, Thompson Zhuang et al. · Journal of Bone and Joint Surgery · 2020 · 36 citations · Full text

Pharmacy, Pharmacoeconomics, Surgery +17

Cost-effectiveness of chimeric antigen receptor T-cell therapy in multiply relapsed or refractory adult large B-cell lymphoma.

John C. Lin, Lori Muffly, Michael A. Spinner et al. · Journal of Clinical Oncology · 2019 · 22 citations

Pharmacy, Oncology, Pharmacoeconomics +17

1–5 of 7